Melanoma Stocks List

Melanoma Stocks Recent News

Date Stock Title
May 3 BFRI Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
May 3 CSTL DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
May 2 CSTL Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ...
May 2 CSTL Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
May 2 CSTL Castle Biosciences beats Q1 estimates, raises FY guidance
May 2 CSTL Castle Biosciences Reports First Quarter 2024 Results
May 2 BCAB BioAtla: A Buried ADC Concern Gets Some New Life In 2024
May 1 CSTL Castle Biosciences Q1 2024 Earnings Preview
May 1 ADAP Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
May 1 IOVA Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
Apr 30 CSTL Castle Biosciences Kicks off Skin Cancer Awareness Month with a Ribbon Cutting to Celebrate the City of Friendswood’s Designation as a Sun Safe Leadership Model City by IMPACT Melanoma
Apr 30 MYGN Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
Apr 29 IOVA With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners
Apr 28 IOVA Where Will Iovance Biotherapeutics Stock Be in 5 Years?
Apr 27 IOVA The Top 3 Biotech Stocks to Buy in April 2024
Melanoma

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of skin pigment. The UV light may be from either the sun or from other sources, such as tanning devices. About 25% develop from moles. Those with many moles, a history of affected family members, and who have poor immune function are at greater risk. A number of rare genetic defects such as xeroderma pigmentosum also increase risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous.Using sunscreen and avoiding UV light may prevent melanoma. Treatment is typically removal by surgery. In those with slightly larger cancers, nearby lymph nodes may be tested for spread. Most people are cured if spread has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment the five-year survival rates in the United States is 98% among those with localized disease and 17% among those in whom spread has occurred. The likelihood that it will come back or spread depends how thick the melanoma is, how fast the cells are dividing, and whether or not the overlying skin has broken down.Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015 there were 3.1 million with active disease which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. There are also high rates in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. Melanoma is more common in men than women. Melanoma has become more common since the 1960s in areas which are mostly populated with white people.

Browse All Tags